Company Profile
Carisma Therapeutics, Inc. Stock Price, News & Analysis
Company overview
Business overview
Carisma Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Carisma Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Carisma Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Carisma Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
CARM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Carisma’s catalysts are macrophage-engineering programs and any strategic or clinical update that clarifies the company’s next path. The company still needs stronger human proof.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
Source: Carisma Therapeutics, Inc.
- 02
Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Source: Carisma Therapeutics, Inc.
- 03
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Source: Carisma Therapeutics, Inc.
- 04
- 05
Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Source: Carisma Therapeutics, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.